WORK Medical Technology Group surges after announcing AI-driven biopharma collaboration featuring “BioTokens”

By: Quiver PriceTracker

Posted: 12 hours ago / May 11, 2026 9:21 p.m. UTC

WOK

WORK Medical Technology Group LTD (WOK) is up 132.8% today. Here is some analysis on what might have caused this price movement.

Analysis: The biggest apparent catalyst is a company press release announcing a strategic cooperation agreement with Shanghai Novabioplus focused on AI-driven protein/antibody R&D and a “BioToken” concept for biological data assets. In a low-float microcap, a thematic AI/Web3 headline can also amplify momentum and drive sharp, news-driven moves.

Details:

The company announced a strategic cooperation agreement with Shanghai Novabioplus (signed April 13, 2026) to jointly develop next-generation intelligent medical models and advance AI-driven biopharmaceutical R&D.

The collaboration outlined four “AI+” project areas: membrane protein design, antibody sequence optimization, enzyme molecule design, and peptide design.

The press release described plans to create “BioTokens” tied to an intelligent digital protein database, aiming to turn certain biopharma R&D outputs into verifiable digital assets.

Earlier in 2026, shareholders approved major capital-structure proposals (including a large increase in authorized share capital and a par-value reduction/reorganization), which can be relevant context for how investors assess dilution and financing flexibility.

Sources:

GlobeNewswire, U.S. Securities and Exchange Commission, Nasdaq

Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

$WOK Hedge Fund Activity

We have seen 0 institutional investors add shares of $WOK stock to their portfolio, and 7 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

SABBY MANAGEMENT, LLC removed 27,240 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $59,383
VIRTU FINANCIAL LLC removed 3,118 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $6,797
UBS GROUP AG removed 2,436 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $2,923
TWO SIGMA SECURITIES, LLC removed 488 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,063
XTX TOPCO LTD removed 381 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $830
BANK OF AMERICA CORP /DE/ removed 2 shares (-66.7%) from their portfolio in Q4 2025, for an estimated $4
CITADEL ADVISORS LLC removed 1 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $2

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.